JP6735224B2 - アストロサイトのグルコース代謝活性化剤 - Google Patents

アストロサイトのグルコース代謝活性化剤 Download PDF

Info

Publication number
JP6735224B2
JP6735224B2 JP2016248774A JP2016248774A JP6735224B2 JP 6735224 B2 JP6735224 B2 JP 6735224B2 JP 2016248774 A JP2016248774 A JP 2016248774A JP 2016248774 A JP2016248774 A JP 2016248774A JP 6735224 B2 JP6735224 B2 JP 6735224B2
Authority
JP
Japan
Prior art keywords
group
tea
hydrophobic solvent
brain
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016248774A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017137296A (ja
JP2017137296A5 (enExample
Inventor
恵子 石田
恵子 石田
幸一 三澤
幸一 三澤
浩二郎 橋爪
浩二郎 橋爪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to EP17743872.8A priority Critical patent/EP3409285A4/en
Priority to CN201780006658.5A priority patent/CN108463234A/zh
Priority to US16/068,408 priority patent/US10925919B2/en
Priority to PCT/JP2017/000023 priority patent/WO2017130638A1/ja
Publication of JP2017137296A publication Critical patent/JP2017137296A/ja
Publication of JP2017137296A5 publication Critical patent/JP2017137296A5/ja
Application granted granted Critical
Publication of JP6735224B2 publication Critical patent/JP6735224B2/ja
Priority to US17/150,093 priority patent/US20210128664A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2016248774A 2016-01-28 2016-12-22 アストロサイトのグルコース代謝活性化剤 Active JP6735224B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP17743872.8A EP3409285A4 (en) 2016-01-28 2017-01-04 AGENT FOR THE ACTIVATION OF ASTROCYTIC GLUCOSE METABOLISM
CN201780006658.5A CN108463234A (zh) 2016-01-28 2017-01-04 星形胶质细胞的葡萄糖代谢激活剂
US16/068,408 US10925919B2 (en) 2016-01-28 2017-01-04 Agent for activating astrocyte glucose metabolism
PCT/JP2017/000023 WO2017130638A1 (ja) 2016-01-28 2017-01-04 アストロサイトのグルコース代謝活性化剤
US17/150,093 US20210128664A1 (en) 2016-01-28 2021-01-15 Agent for Activating Astrocyte Glucose Metabolism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016013957 2016-01-28
JP2016013957 2016-01-28

Publications (3)

Publication Number Publication Date
JP2017137296A JP2017137296A (ja) 2017-08-10
JP2017137296A5 JP2017137296A5 (enExample) 2019-11-14
JP6735224B2 true JP6735224B2 (ja) 2020-08-05

Family

ID=59564595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016248774A Active JP6735224B2 (ja) 2016-01-28 2016-12-22 アストロサイトのグルコース代謝活性化剤

Country Status (4)

Country Link
US (2) US10925919B2 (enExample)
EP (1) EP3409285A4 (enExample)
JP (1) JP6735224B2 (enExample)
CN (1) CN108463234A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7025145B2 (ja) * 2017-07-13 2022-02-24 株式会社メガチップス 電子メロディ特定装置、プログラム、及び電子メロディ特定方法
JP7088777B2 (ja) * 2018-08-09 2022-06-21 花王株式会社 Ｇｌｕｔ１発現亢進剤
EP3847260A4 (en) * 2018-09-07 2022-09-07 SOTIO Biotech Inc. CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANSMETABOLIC MOLECULES THAT MODULATE INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF
CN114457045B (zh) * 2022-02-25 2023-07-14 中国人民解放军军事科学院军事医学研究院 抑制Slc2a1的RNAi腺相关病毒及其制备和应用
WO2025127072A1 (ja) * 2023-12-14 2025-06-19 協和ファーマケミカル株式会社 グルコーストランスポーター１の発現促進剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01283227A (ja) 1988-05-02 1989-11-14 Nonogawa Shoji:Kk 抗変異原剤
JPH05246866A (ja) 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk 脳代謝促進・脳機能改善剤
JP3241609B2 (ja) 1996-09-20 2001-12-25 サントリー株式会社 甜茶抽出物を有効成分とする医薬並びにこれを配合した食品および化粧品
DE69942672D1 (de) 1998-12-17 2010-09-23 Mindset Biopharmaceuticals Usa Verbesserung der geistigen fähigkeiten durch die steigerung der insulin-empfindlichkeit des gehirns
CN1370528A (zh) 2001-02-21 2002-09-25 陈建操 治疗失眠、精神和心理障碍疾病的药物
US20040253647A1 (en) * 2001-06-26 2004-12-16 Mathews Paul M. Cell-based high-throughput screening methods
JP2004307443A (ja) 2003-04-10 2004-11-04 Shiseido Co Ltd カスパーゼ−９活性阻害剤含有組成物
KR20070078527A (ko) * 2006-01-27 2007-08-01 초임계연구소 주식회사 초임계 이산화탄소를 이용한 카페인이 제거된 차의제조방법
JP2007297304A (ja) 2006-04-28 2007-11-15 Kao Corp 大脳疲労回復剤
PT2053050E (pt) * 2007-10-23 2011-12-09 Kneipp Werke Kneipp Mittel Zentrale Gmbh & Co Kg Di-hidrocalcona idêntica a aspalatina e método para a sua preparação
WO2009137818A1 (en) 2008-05-09 2009-11-12 Mount Sinai School Of Medicine Of New York University Methods for preventing and treating neurodegenerative diseases
FR2934160B1 (fr) 2008-07-25 2012-12-07 Lvmh Rech Procede de preparation d'un extrait lipophile de vigne.
EP2161026B1 (de) 2008-09-05 2012-12-26 Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & Co. KG Kombination von Extrakten aus verschiedenen Pflanzen zur Verbesserung der Symptome von Demenzerkrankungen
KR100997078B1 (ko) 2009-04-29 2010-11-29 (주)보성녹차테크 다엽 식용유 및 그 제조방법
US20130059019A1 (en) 2009-12-18 2013-03-07 Exodus Life Sciences Limited Partnership Methods and compositions for treating inflammation of skin
CA2856592C (en) * 2011-11-29 2017-05-30 Amino Up Chemical Co., Ltd. Vicenin 2 and analogues thereof for use as an antispasmodic and/or prokinetic agent
JP6217038B2 (ja) 2012-02-03 2017-10-25 学校法人同志社 蛋白質糖化反応阻害剤
CN102613345A (zh) * 2012-04-17 2012-08-01 徐州绿之野生物食品有限公司 银杏红茶及其制备方法
CN102669345A (zh) * 2012-05-20 2012-09-19 北京绿源求证科技发展有限责任公司 一种养脑的营养食品养脑茶冲剂
JP2014118406A (ja) 2012-12-19 2014-06-30 Concord Co Ltd Ｏｐｈ活性増強剤
WO2014123305A2 (ko) * 2013-02-08 2014-08-14 주식회사 파미니티 민들레 추출물 또는 민들레 함유 복합 추출물을 유효성분으로 하는 남성 갱년기 예방, 개선 또는 치료용 조성물
CN103087828B (zh) 2013-02-21 2016-04-27 云南天宏香精香料有限公司 一种滇红精油及其制备方法
CN103749919B (zh) * 2013-12-27 2015-04-22 北京康比特体育科技股份有限公司 一种提神醒脑的凝胶型糖果及其制备方法
CN104322736A (zh) * 2014-10-10 2015-02-04 张成海 一种袋装植物型醒脑提神茶饮
CN105037569B (zh) * 2015-05-19 2017-11-03 湘潭大学 一种甜叶悬钩子水溶性多糖用于保护肝脏及激活乙醛脱氢酶的应用
CN105237598B (zh) 2015-09-24 2017-12-22 安徽农业大学 一种名为茶山奈苷b的黄酮氧苷类化合物及其制备方法和应用
JP2018177748A (ja) 2017-04-21 2018-11-15 花王株式会社 アストロサイトのグルコース代謝活性化剤

Also Published As

Publication number Publication date
JP2017137296A (ja) 2017-08-10
CN108463234A (zh) 2018-08-28
US20190015469A1 (en) 2019-01-17
EP3409285A4 (en) 2019-07-31
US20210128664A1 (en) 2021-05-06
US10925919B2 (en) 2021-02-23
EP3409285A1 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
US20210128664A1 (en) Agent for Activating Astrocyte Glucose Metabolism
JP7379152B2 (ja) 筋線維化抑制用組成物
EP2893931A1 (en) Growth hormone secretagogue
EP3622952A1 (en) Agent for promoting decomposition and excretion of amyloid-
KR102612706B1 (ko) 시계 유전자의 발현을 변화시키기 위한 조성물
KR20160107420A (ko) 진세노사이드 f2를 포함하는 비알코올성 간 질환 또는 인슐린 저항성의 예방 또는 치료용 조성물
US10406187B2 (en) Method for treating neuroinflammation with a pharmaceutical composition containing Portulaca grandiflora hook. extract or fraction thereof as active ingredient
KR101401612B1 (ko) 석류 추출물을 유효성분으로 포함하는 스트레스성 질환의 치료 및 예방용 조성물
JP2018177748A (ja) アストロサイトのグルコース代謝活性化剤
JP2006232781A (ja) アカシア属樹皮由来物を含有する血糖降下組成物
KR100640094B1 (ko) 콜레스테롤 저하 또는 항산화 활성을 갖는 녹차씨유를 포함하는 조성물
JP7011400B2 (ja) アストロサイトのグルコース代謝活性化剤
KR102135295B1 (ko) 넓패 추출물을 유효성분으로 하는 근지구력 증강용 조성물
WO2017130638A1 (ja) アストロサイトのグルコース代謝活性化剤
KR101929353B1 (ko) 항우울 또는 항불안 활성을 갖는 쥐오줌풀 어린잎 추출물을 함유하는 조성물
JP7595137B2 (ja) 脳デトックス促進剤
JP7610209B2 (ja) ミトコンドリア活性向上用組成物
KR102323577B1 (ko) 부채마와 백년초의 혼합추출물을 포함하는 우울증 예방 또는 치료용 조성물
EP4289438A1 (en) Composition for preventing, alleviating or treating sleep disorders, containing, as active ingredient, gut microbiota or extracellular vesicles derived therefrom
US8128969B2 (en) Hypoglycemic composition containing acacia bark derivative
US20230293482A1 (en) Central nervous system potentiating composition
JP2017206477A (ja) 筋形成促進用組成物
JP2020105117A (ja) 脳グルコース代謝活性化剤
JP2025096926A (ja) 分枝鎖アミノ酸取り込み促進用組成物
KR20250097662A (ko) 하고초 추출물을 유효성분으로 포함하는 근육질환의 예방, 개선 또는 치료용 조성물

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191002

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20191002

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20191017

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200622

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200707

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200713

R151 Written notification of patent or utility model registration

Ref document number: 6735224

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250